Thomas Rotter
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Thomas Rotter has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Leigh Kinsman
Violet Vines Marshman Centre for Rural Health Research, La Trobe University Bendigo, Australia
3 shared publications Andreas Machotta
Department of Anaesthesiology, Sophia Children’s Hospital, Erasmus University Rotterdam, Rotterdam, The Netherlands
2 shared publicationsErica James
Centre for Health Research and Psycho-oncology (CHeRP), Cancer Council NSW & University of Newcastle, Newcastle, Australia
2 shared publicationsJoachim Kugler
Department of Public Health, Dresden Medical School, University of Dresden, Dresden, Germany
2 shared publications- Jon Willis
Aboriginal & Torres Strait Islander Studies Unit, University of Queensland, Brisbane, Queensland, Australia
2 shared publications - Pamela Claire Snow
School of Education, La Trobe University
2 shared publications
Latest Publications
- Open Access
- 18 June 2012
- Published by Springer Nature in BMC Medical Research Methodology
- Vol. 12 (1) , 80
The quality of the evidence base for clinical pathway effectiveness: Room for improvement in the design of evaluation trials
The purpose of this article is to report on the quality of the existing evidence base regarding the effectiveness of clinical pathway (CPW) research in the hospital setting. The analysis is based on a recently published Cochrane review of the effectiveness of CPWs. An integral component of the review process was a rigorous appraisal of the methodological quality of published CPW evaluations. This allowed the identification of strengths and limitations of the evidence base for CPW effectiveness. We followed the validated Cochrane Effective Practice and Organisation of Care Group (EPOC) criteria for randomized and non-randomized clinical pathway evaluations. In addition, we tested the hypotheses that simple pre-post studies tend to overestimate CPW effects reported. Out of the 260 primary studies meeting CPW content criteria, only 27 studies met the EPOC study design criteria, with the majority of CPW studies (more than 70 %) excluded from the review on the basis that they were simple pre-post evaluations, mostly comparing two or more annual patient cohorts. Methodologically poor study designs are often used to evaluate CPWs and this compromises the quality of the existing evidence base. Cochrane EPOC methodological criteria, including the selection of rigorous study designs along with detailed descriptions of CPW development and implementation processes, are recommended for quantitative evaluations to improve the evidence base for the use of CPWs in hospitals.
- 18 June 2012
- Published by Springer Nature in BMC Medical Research Methodology
- Vol. 12 (1) , 80
Open AccessThe quality of the evidence base for clinical pathway effectiveness: Room for improvement in the design of evaluation trials
The purpose of this article is to report on the quality of the existing evidence base regarding the effectiveness of clinical pathway (CPW) research in the hospital setting. The analysis is based on a recently published Cochrane review of the effectiveness of CPWs. An integral component of the review process was a rigorous appraisal of the methodological quality of published CPW evaluations. This allowed the identification of strengths and limitations of the evidence base for CPW effectiveness. We followed the validated Cochrane Effective Practice and Organisation of Care Group (EPOC) criteria for randomized and non-randomized clinical pathway evaluations. In addition, we tested the hypotheses that simple pre-post studies tend to overestimate CPW effects reported. Out of the 260 primary studies meeting CPW content criteria, only 27 studies met the EPOC study design criteria, with the majority of CPW studies (more than 70 %) excluded from the review on the basis that they were simple pre-post evaluations, mostly comparing two or more annual patient cohorts. Methodologically poor study designs are often used to evaluate CPWs and this compromises the quality of the existing evidence base. Cochrane EPOC methodological criteria, including the selection of rigorous study designs along with detailed descriptions of CPW development and implementation processes, are recommended for quantitative evaluations to improve the evidence base for the use of CPWs in hospitals.
- Open Access
- 10 February 2012
- Published by Springer Nature in Systematic Reviews
- Vol. 1 (1) , 11
Methods for the evaluation of hospital cooperation activities (Systematic review protocol)
Hospital partnerships, mergers and cooperatives are arrangements frequently seen as a means of improving health service delivery. Many of the assumptions used in planning hospital cooperatives are not stated clearly and are often based on limited or poor scientific evidence.
- 10 February 2012
- Published by Springer Nature in Systematic Reviews
- Vol. 1 (1) , 11
Open AccessMethods for the evaluation of hospital cooperation activities (Systematic review protocol)
Hospital partnerships, mergers and cooperatives are arrangements frequently seen as a means of improving health service delivery. Many of the assumptions used in planning hospital cooperatives are not stated clearly and are often based on limited or poor scientific evidence.
- 24 May 2011
- Published by SAGE Publications in Evaluation & the Health Professions
- Vol. 35 (1) , 43-46
Have We Drawn the Wrong Conclusions About the Value of Care Pathways? Is a Cochrane Review Appropriate? Response to the Commentary Article Published by Kris Vanhaecht et al.
The commentary provided by Vanhaecht et al. from the European Pathways Association (EPA) questions whether conclusions derived from the review of effects of clinical pathways in hospitals are appropriate. They provide some methodological discussion that indicates a poor appreciation of the detailed content of the review as published in the Cochrane Library and a lack of understanding of the methodological requirements for complex interventions of the Cochrane Effective Practice and Organisation of Care (EPOC) group. In addition, Vanhaecht et al. misrepresent some important points from the review relating to the intervention reviewed. The critical commentary offered by Vanhaecht et al. is a misrepresentation of the process and content of the review and suggests they have not taken the time and effort to thoroughly read and understand this comprehensive review.
- 24 May 2011
- Published by SAGE Publications in Evaluation & the Health Professions
- Vol. 35 (1) , 43-46
Have We Drawn the Wrong Conclusions About the Value of Care Pathways? Is a Cochrane Review Appropriate? Response to the Commentary Article Published by Kris Vanhaecht et al.
The commentary provided by Vanhaecht et al. from the European Pathways Association (EPA) questions whether conclusions derived from the review of effects of clinical pathways in hospitals are appropriate. They provide some methodological discussion that indicates a poor appreciation of the detailed content of the review as published in the Cochrane Library and a lack of understanding of the methodological requirements for complex interventions of the Cochrane Effective Practice and Organisation of Care (EPOC) group. In addition, Vanhaecht et al. misrepresent some important points from the review relating to the intervention reviewed. The critical commentary offered by Vanhaecht et al. is a misrepresentation of the process and content of the review and suggests they have not taken the time and effort to thoroughly read and understand this comprehensive review.
- 24 May 2011
- Published by SAGE Publications in Evaluation & the Health Professions
- Vol. 35 (1) , 3-27
The Effects of Clinical Pathways on Professional Practice, Patient Outcomes, Length of Stay, and Hospital Costs
This paper is a summary version of the previously published Cochrane review. It may increase the reach of the topic to health researchers and practitioners and encourage further discussion. The systematic review aims to summarize the evidence and assess the effect of clinical pathways on professional practice, patient outcomes, length of hospital stay, and hospital costs. The authors searched the Database of Abstracts of Reviews of Effectiveness, the Effective Practice and Organisation of Care Register, the Cochrane Central Register of Controlled Trials and bibliographic databases including MEDLINE, EMBASE, CINAHL, NHS EED, and Global Health. Twenty-seven studies considering a total of 11,398 participants were included for analysis. The main results were a reduction in in-hospital complications (odds ratio 0.58: 95% CI [0.36, 0.94] and improved documentation (odds ratio 11.95: 95% CI [4.72, 30.30]) associated with clinical pathways. Considerable variation in study design and settings prevented statistical pooling of results for length of stay (LOS) and hospital costs. The authors concluded that clinical pathways are associated with reduced in-hospital complications and improved documentation.
- 24 May 2011
- Published by SAGE Publications in Evaluation & the Health Professions
- Vol. 35 (1) , 3-27
The Effects of Clinical Pathways on Professional Practice, Patient Outcomes, Length of Stay, and Hospital Costs
This paper is a summary version of the previously published Cochrane review. It may increase the reach of the topic to health researchers and practitioners and encourage further discussion. The systematic review aims to summarize the evidence and assess the effect of clinical pathways on professional practice, patient outcomes, length of hospital stay, and hospital costs. The authors searched the Database of Abstracts of Reviews of Effectiveness, the Effective Practice and Organisation of Care Register, the Cochrane Central Register of Controlled Trials and bibliographic databases including MEDLINE, EMBASE, CINAHL, NHS EED, and Global Health. Twenty-seven studies considering a total of 11,398 participants were included for analysis. The main results were a reduction in in-hospital complications (odds ratio 0.58: 95% CI [0.36, 0.94] and improved documentation (odds ratio 11.95: 95% CI [4.72, 30.30]) associated with clinical pathways. Considerable variation in study design and settings prevented statistical pooling of results for length of stay (LOS) and hospital costs. The authors concluded that clinical pathways are associated with reduced in-hospital complications and improved documentation.